Rhumbline Advisers Harmony Biosciences Holdings, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 92,051 shares of HRMY stock, worth $3.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

92,051

Previous 100,694 8.58%

Holding current value

$3.14 Million

Previous $3.04 Million 21.07%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$30.0 - $39.95 $259,290 - $345,287	-8,643 Reduced 8.58%	92,051 $3.68 Million
Q2 2024 Aug 01, 2024	SELL	$28.81 - $33.01 $98,559 - $112,927	-3,421 Reduced 3.29%	100,694 $3.04 Million
Q1 2024 May 09, 2024	BUY	$29.93 - $35.06 $106,850 - $125,164	3,570 Added 3.55%	104,115 $3.5 Million
Q4 2023 Feb 08, 2024	SELL	$19.2 - $33.78 $35,251 - $62,020	-1,836 Reduced 1.79%	100,545 $3.25 Million
Q3 2023 Nov 09, 2023	BUY	$31.89 - $39.03 $239,653 - $293,310	7,515 Added 7.92%	102,381 $3.36 Million
Q2 2023 Aug 08, 2023	BUY	$30.5 - $37.4 $317,932 - $389,857	10,424 Added 12.34%	94,866 $3.34 Million
Q1 2023 May 11, 2023	BUY	$30.8 - $53.92 $140,355 - $245,713	4,557 Added 5.7%	84,442 $2.76 Million
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $18,750 - $25,155	413 Added 0.52%	79,885 $4.4 Million
Q3 2022 Nov 10, 2022	BUY	$42.06 - $55.45 $549,934 - $725,008	13,075 Added 19.69%	79,472 $3.52 Million
Q2 2022 Aug 11, 2022	BUY	$33.54 - $52.15 $238,335 - $370,577	7,106 Added 11.98%	66,397 $3.24 Million
Q1 2022 May 12, 2022	BUY	$33.14 - $51.13 $188,964 - $291,543	5,702 Added 10.64%	59,291 $2.89 Million
Q4 2021 Feb 10, 2022	BUY	$34.09 - $43.91 $1.14 Million - $1.47 Million	33,492 Added 166.65%	53,589 $2.29 Million
Q3 2021 Nov 12, 2021	BUY	$25.68 - $38.61 $28,170 - $42,355	1,097 Added 5.77%	20,097 $770,000
Q2 2021 Aug 05, 2021	BUY	$25.96 - $33.44 $493,240 - $635,360	19,000 New	19,000 $536,000

Others Institutions Holding HRMY

# of Institutions

242

Shares Held

45.2M

Call Options Held

108K

Put Options Held

49.2K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Harmony Biosciences Holdings, Inc. Transaction History